Haslbauer, Ferdinand
Petzer, Andreas
Safanda, Martin
Tomova, Antoaneta
Porubska, Miriam
Bajory, Zoltán
Niepel, Daniela
Jaeger, Christine
Bjorklof, Katja
Kalinin, Dmitry
Greil, Richard
Funding for this research was provided by:
Amgen (Not applicable)
Article History
Received: 14 March 2019
Accepted: 8 July 2019
First Online: 26 July 2019
Compliance with ethical standards
: This study complied with all relevant national requirements on a country-by-country basis. Written informed consent was obtained from the patient or legally acceptable representative. National ethics committee approval of the protocol and informed consent form was obtained before recruitment of patients or any data collection.
: Ferdinand Haslbauer, Martin Safanda, Antoaneta Tomova, Zoltán Bajory, Miriam Porubska, and Dmitry Kalinin have no conflicts of interest to declare. Andreas Petzer declares to hold a non-remunerative position of influence as advisory board member of Amgen and has received speaker honoraria of Amgen. Richard Greil has received research grants from Celgene, Merck, Roche, Takeda, AstraZeneca, Novartis, Amgen and BMS, and consulting fees from Celgene, Roche, BMS, Takeda, Abbvie, AstraZeneca, and Novartis. Christine Jaeger, Katja Bjorklof, and Daniela Niepel are employees of Amgen and hold Amgen stock.